An intensive lifestyle intervention centered on weight loss and physical activity reduced the incidence of type 2 diabetes by 58% over three years, compared with placebo, in the Diabetes Prevention Program (DPP), a US National Institutes of Health randomized trial of 3,234 adults with prediabetes reported by Knowler and colleagues in the New England Journal of Medicine in 2002. That result, together with subsequent trials, established the evidence base for what is now called lifestyle medicine, a recognized specialty formalized by Lianov and Johnson in the Journal of the American Medical Association in 2010. The term “holistic wellness” is used to describe both this evidence-based approach and a much broader set of practices with little controlled evidence.
Lifestyle medicine has an accepted definition
Lifestyle medicine is defined by the American College of Lifestyle Medicine and by the Lianov and Johnson competencies as the evidence-based clinical practice of preventing, treating, and often reversing chronic diseases caused by unhealthful lifestyle factors. The 2010 JAMA commentary and its 2022 update in the American Journal of Lifestyle Medicine specify six pillars: a whole-food, plant-predominant eating pattern; regular physical activity; restorative sleep; management of stress; avoidance of risky substance use (tobacco, excessive alcohol, other drugs of misuse); and positive social connections. Board certification for physicians in this specialty has existed since 2017 through the American Board of Lifestyle Medicine.
The randomized trial evidence is strongest for cardiovascular and metabolic disease
The DPP is the largest and most cited randomized trial of intensive lifestyle intervention in a disease-prevention context. Participants randomized to lifestyle intervention aimed for a 7% weight loss and at least 150 minutes of moderate-intensity activity per week. After a mean 2.8 years, the incidence of type 2 diabetes was 4.8 cases per 100 person-years in the lifestyle group against 11.0 in the placebo group. The Finnish Diabetes Prevention Study and the Chinese Da Qing Study produced similar reductions in different populations. Comparable evidence supports lifestyle interventions for the primary prevention of cardiovascular disease, and for improving outcomes in existing hypertension, dyslipidemia, and early coronary artery disease. The mechanistic story is not novel: weight loss, better cardiorespiratory fitness, and improved insulin sensitivity are the levers. The DPP authors concluded that “lifestyle changes and treatment with metformin both reduced the incidence of diabetes in persons at high risk. The lifestyle intervention was more effective than metformin.”
The evidence for other pillars is more variable
The evidence base thins as the pillars move from diet and activity to sleep, stress, and social connection. Sleep restriction has clear cardiometabolic effects in controlled experiments, but interventions to improve sleep in the general population have produced smaller and more variable effects on hard outcomes than dietary or activity interventions. Stress management practices, including mindfulness-based stress reduction, have moderate evidence for effects on blood pressure, chronic pain, and depression, though effect sizes are usually modest. Social connection is one of the most consistent longitudinal predictors of health outcomes in observational cohorts, but interventions to increase social connection are harder to design and have been tested at smaller scale.
The commercial wellness industry runs ahead of the evidence
Many products and services marketed under “holistic wellness” borrow the credibility of the lifestyle-medicine evidence base while making claims that are neither tested nor plausible. Three categories account for most of the excess.
“Detox” products claim to remove toxins from the liver, kidneys, or bloodstream. Those organs already perform this function continuously, and no supplement, tea, or cleanse has been shown in randomized trials to enhance their capacity. The concept of dietary detoxification, as understood by clinical toxicology, is limited to specific poisoning treatments, not routine wellness.
“Immunity boosters” imply that the immune system is a resource that can be increased. In practice, immune function is complex and tightly regulated, and in generally healthy adults it is not meaningfully augmented by supplement doses of common vitamins, adaptogens, or antioxidants. Correcting a documented deficiency (vitamin D, zinc, iron) helps if the deficiency exists; adding supplements on top of sufficiency does not.
Testimonials substituting for controlled evidence are the most consistent tell. Anecdotes from satisfied customers are compatible with any explanation, including placebo response, regression to the mean, and natural resolution of self-limiting symptoms. Randomized controlled trials exist to remove those confounders.
Where alternative practices do have evidence, it is worth naming
Not every practice in the broader wellness category is without evidence. Mindfulness-based stress reduction has randomized trial support for anxiety, depression, and chronic pain. Yoga has trial evidence for low back pain and, in some studies, blood pressure. Acupuncture has moderate evidence for chronic pain in some indications. Cognitive behavioral therapy for insomnia is now the first-line treatment for that condition ahead of sleep medications. Naming what works separates the evidence-based portion of the wellness landscape from the parts that borrow its authority without earning it.
What the evidence cannot yet answer
The clean randomized trial evidence for lifestyle-medicine interventions is strongest in the disease-prevention context of high-risk populations (people with prediabetes, hypertension, elevated cholesterol) and weaker for maintenance of health in already-healthy adults with no risk factors, where absolute event rates are low and trials become impractical. Whether specific dietary patterns (Mediterranean, DASH, plant-based, low-carbohydrate) are meaningfully different from each other for long-term outcomes remains contested; head-to-head trials at the required scale and duration have not been done. And the evidence base for interventions targeting sleep, stress, and social connection is thinner than the confident marketing suggests, though the direction of effect appears consistent.
References
- Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine, 2002; 346: 393-403. DOI: 10.1056/NEJMoa012512
- Lianov L, Johnson M. Physician competencies for prescribing lifestyle medicine. JAMA, 2010; 304: 202-203. DOI: 10.1001/jama.2010.903
- Lianov LS, Adamson K, Kelly JH, et al. Lifestyle Medicine Core Competencies: 2022 Update. American Journal of Lifestyle Medicine, 2022; 16: 734-739. DOI: 10.1177/15598276221121580
- American College of Lifestyle Medicine. Evidence base and clinical practice framework. Available at: lifestylemedicine.org